Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder

J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):316-20. doi: 10.1097/01.mpg.0000189333.85268.b9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology*
  • Antigens, CD20 / therapeutic use
  • Antineoplastic Agents / immunology
  • Antineoplastic Agents / therapeutic use*
  • Child, Preschool
  • Fatal Outcome
  • Humans
  • Liver Transplantation / adverse effects*
  • Lymphoproliferative Disorders / drug therapy*
  • Lymphoproliferative Disorders / etiology*
  • Lymphoproliferative Disorders / immunology
  • Male
  • Risk Factors
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents
  • Rituximab